Melbourne, Australia; Starpharma Holdings Ltd (ASX: SPL, OTCQX: SPHRY) today announced that Chief Executive Officer, Dr Jackie Fairley will present at both the leading ROTH Conference in California and the ASX Spotlight conference in New York in the coming week. These conferences both provide the opportunity for Starpharma to present the business to US investors.

Dr Fairley will first present at the ASX Spotlight New York 2015 in New York this Thursday, March 5 at 9.25am US Eastern Time. She will present alongside 13 other executives from ASX-listed biotechnology, technology and resource companies and will participate in one-on-one meetings with US investors.

The Australian Federal Minister for Trade and Investment, the Hon Andrew Robb AO, MP, will also be hosting a panel session at the event which is expected to be attended by more than 160 US investors.

Dr Fairley will also present at the 27^th Annual ROTH Conference in California, on Monday, March 9 at 2pm US Pacific Time. Over 3,000 participants, representing institutional investors, private equity investors, company executives and service providers attend the conference, which is focused on small- and mid-cap companies.

View ASX Spotlight Presentation: ASX Spotlight New York Presentation (pdf file, 2MB)

View the ROTH Webcast: Click here to access the external link (available for approx. 90 days)